Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tivozanib hydrochloride hydrate is a selective, potent, orally active VEGFR tyrosine kinase inhibitor that acts on VEGFR-1 (IC50: 0.21 nM), VEGFR-2 (IC50: 0.16 nM), and VEGFR-3 (IC50: 0.24 nM). Tivozanib hydrochloride hydrate inhibits angiogenesis and vascular permeability in tumor tissue and has antitumor effects that have potential for investigation in metastatic renal cell carcinoma (RCC).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 53.00 | |
10 mg | In stock | $ 74.00 | |
25 mg | In stock | $ 118.00 | |
50 mg | In stock | $ 173.00 | |
100 mg | In stock | $ 256.00 | |
500 mg | In stock | $ 638.00 |
Description | Tivozanib hydrochloride hydrate is a selective, potent, orally active VEGFR tyrosine kinase inhibitor that acts on VEGFR-1 (IC50: 0.21 nM), VEGFR-2 (IC50: 0.16 nM), and VEGFR-3 (IC50: 0.24 nM). Tivozanib hydrochloride hydrate inhibits angiogenesis and vascular permeability in tumor tissue and has antitumor effects that have potential for investigation in metastatic renal cell carcinoma (RCC). |
Molecular Weight | 509.34 |
Formula | C22H22Cl2N4O6 |
CAS No. | 682745-41-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tivozanib hydrochloride hydrate 682745-41-1 inhibitor inhibit